Aarti Industries Limited (AARTIIND)

Chemicals · Chemicals & Petrochemicals · NSE · Updated 21 July 2026
₹499.5 ↑ 13.03% (1Y)

🎯 Key Takeaways

  • Aarti Industries Limited is in a strategic reinvestment phase, transitioning from mature growth to a capital-intensive expansion focused on backward integration and long-term supply agreements. Management is actively reshaping its portfolio to enhance resilience and margin sustainability, as evidenced by recent capex commitments and strategic partnerships extending to 2030.
  • Revenue declined 4.9% QoQ to ₹2,206 in Q4FY26.
  • ⚠️ 1) Raw material inflation and working capital pressures remain unmitigated risks, as explicitly flagged by management. 2) Execution risk around the ba
Market Cap
₹16,906
P/E Ratio
40.3
P/B Ratio
2.84
ROE
7.1%
ROCE
6.5%
Debt/Equity
0.83
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Aarti Industries Limited is in a strategic reinvestment phase, transitioning from mature growth to a capital-intensive expansion focused on backward integration and long-term supply agreements. Management is actively reshaping its portfolio to enhance resilience and margin sustainability, as evidenced by recent capex commitments and strategic partnerships extending to 2030.

📰 What's Happening

In FY26, the company secured a $150 million multiyear agrochemical supply agreement through 2030 and launched a backward integration project with a global chemical firm, investing INR 200-250 crore in capex. FY26 capex was INR 1,125 crore, with FY27 expected to moderate to INR 700-800 crore. Revenue growth of 12% YoY in FY26 was driven by strong Q4 performance and operational resilience amid Middle East supply chain disruptions. Management highlighted these initiatives as central to long-term value creation during the Q1 FY27 earnings call scheduled for July 31, 2026.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ1FY25Q2FY25Q3FY25Q4FY25Q1FY26Q2FY26Q3FY26Q4FY26
Revenue1,8551,6281,8401,9491,6762,1002,3192,206
Operating Profit311204236266216314308342
OPM %16.4%12.1%12.6%13.8%12.7%13.9%13.9%15.5%
Net Profit13752469643106133137
EPS₹3.77₹1.44₹1.27₹2.64₹1.19₹2.91₹3.67₹3.79

Revenue has shown consistent YoY growth, rising from ₹1,628 crore in Q2FY25 to ₹2,206 crore in Q4FY26, with EBITDA and PAT expanding significantly. Operating margins have stabilized around 13-15.5% in recent quarters, supporting profitability despite input cost pressures. The surge in PAT and EPS in FY26 reflects improved execution and scale benefits, though margins remain sensitive to raw material inflation, which management is actively managing through strategic sourcing and integration.

🔮 Management Outlook & What's Next

Management expressed confidence in sustained growth momentum, citing the long-term supply agreement and backward integration project as key catalysts. They emphasized resilience to external shocks and a focus on strengthening operational efficiency. The Q1 FY27 earnings call on July 31, 2026, will provide a platform for deeper insights into performance drivers and future capital allocation plans, as noted in investor communications dated May 11 and June 23, 2026.

Extracted from official company announcements. Not StockFin.ai's opinion.

🏦 Balance Sheet (₹ Cr)

Item2024-20252025-20262025-20262025-20262025-2026
Equity Capital181181181181181
Reserves5,4245,5315,774
Borrowings3,9224,921
Total Liabilities5,9907,345
Fixed Assets6,3296,3516,265
Investments4881132
Total Assets11,11411,70213,300

The balance sheet reflects a deliberate shift toward capital deployment, with total assets growing to ₹13,300 crore and borrowings at ₹4,921 crore in the latest period. While equity remains stable at ₹181 crore, reserves have increased, indicating retained earnings. Capex is being scaled down in FY27, suggesting a transition from aggressive investment to operational optimization, with net debt expected to decline as per management commentary.

💰 Cash Flow Statement (₹ Cr)

Item2020-20212020-2021
Operating+251+873
Investing-533-1,322
Financing+300+614
Net Cash Flow

⚖️ Peer Comparison — Chemicals & Petrochemicals

Company MCap (₹ Cr) P/E ROCE ROE D/E
Solar Industries India Limited 1.57 L Cr 132.3
Pidilite Industries Limited 1.49 L Cr 75.7
SRF Limited 79,723 69.5
Linde India Limited 62,701 141.9
Gujarat Fluorochemicals Limited 40,793 89.6
Navin Fluorine International Limited 35,894 131.5
Himadri Speciality Chemical Limited 30,071 56.6
Deepak Nitrite Limited 24,911 33.3
Atul Limited 20,904 48.8
Tata Chemicals Limited 19,079 -47.1

⚠️ Risk Factors

1) Raw material inflation and working capital pressures remain unmitigated risks, as explicitly flagged by management. 2) Execution risk around the backward integration project and its impact on cost structure and timelines. 3) Dependence on a concentrated revenue exposure of 9-10% to the Middle East market introduces geopolitical and demand volatility. 4) High leverage (D/E of 0.83) necessitates disciplined cash flow management amid ongoing capex cycles.

📋 Recent Filings

🧠 Analyst's Read

Aarti Industries is executing a clear strategic pivot toward long-term contracts and backward integration, supported by rising profitability and capex moderation. Investors should monitor management's commentary in the upcoming Q1 FY27 earnings call for updates on integration progress, margin outlook, and debt reduction trajectory.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-21.

📡 Get AI alerts when AARTIIND files new disclosures

Track AARTIIND filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AARTIIND — Free

Free account · 2 AI queries/day